Immunovant Inc (IMVT)
26.54
+0.37
(+1.41%)
USD |
NASDAQ |
Nov 21, 16:00
26.54
0.00 (0.00%)
After-Hours: 20:00
Immunovant Shareholders Equity (Quarterly): 449.05M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 449.05M |
| June 30, 2024 | 544.66M |
| March 31, 2024 | 617.76M |
| December 31, 2023 | 679.34M |
| September 30, 2023 | 251.81M |
| June 30, 2023 | 299.86M |
| March 31, 2023 | 362.49M |
| December 31, 2022 | 414.68M |
| September 30, 2022 | 395.75M |
| June 30, 2022 | 436.49M |
| March 31, 2022 | 469.82M |
| December 31, 2021 | 505.15M |
| Date | Value |
|---|---|
| September 30, 2021 | 536.40M |
| June 30, 2021 | 365.53M |
| March 31, 2021 | 391.48M |
| December 31, 2020 | 414.15M |
| September 30, 2020 | 438.41M |
| June 30, 2020 | 267.78M |
| March 31, 2020 | 94.07M |
| December 31, 2019 | 111.86M |
| September 30, 2019 | 113.42M |
| June 30, 2019 | 113.30M |
| March 31, 2019 | 0.0241M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
94.07M
Minimum
Mar 2020
679.34M
Maximum
Dec 2023
402.33M
Average
414.42M
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Electromed Inc | 41.49M |
| Xtant Medical Holdings Inc | 45.72M |
| Myomo Inc | 9.292M |
| Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 515.71M |
| Total Liabilities (Quarterly) | 66.65M |